Genetic analysis of ADIPOQ variants and gastric cancer risk: A hospital-based case-control study in China

Medical Oncology

Volumn 30, Issue 3, 2013, Pages

  Ye, Lei ^a   Zhang, Zuo Yang ^a   Du, Wei Dong ^a,b   Schneider, Marion E ^b   Qiu, Yue ^a   Zhou, Yuan ^a   Zhou, Fu Sheng ^a   Zuo, Xian Bo ^a   Chen, Gang ^a   Ma, Xue Ling ^c   Xia, Hong Zhen ^a   Xu, Song ^a   Wu, Ji Feng ^a   Xu, Hong Yuan ^a   Zhang, Xue Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c MVZ   (Germany)

Author keywords

Adiponectin; Adiponectin receptors; Gastric cancer; Immunohistochemistry; Single nucleotide polymorphism

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; GENOMIC DNA; ADIPONECTIN RECEPTOR; ADIPOQ PROTEIN, HUMAN; ADIPOR1 PROTEIN, HUMAN; ADIPOR2 PROTEIN, HUMAN; TUMOR MARKER;

ADIPOQ GENE; ADIPOQ1 GENE; ADIPOQ2 GENE; ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CARDIA; CHINA; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GASTRECTOMY; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIMARY TUMOR; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; TISSUE MICROARRAY; TUMOR INVASION; TUMOR LOCALIZATION; VERY ELDERLY; ASIAN; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; RISK; STOMACH TUMOR; YOUNG ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; STOMACH NEOPLASMS;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADIPONECTIN; RISK; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84880335607     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0658-9     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
2. Wex T, Bornschein J, Malfertheiner P. Host polymorphisms of immune regulatory genes as risk factors for gastric cancer. Minerva Gastroenterol Dietol. 2009;55(4):395-408.
3. Barresi V, Grosso M, Giuffre G, Tuccari G, Barresi G. The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. J Clin Pathol. 2009;62(8):705-9. doi: 10.1136/jcp.2009.066175.
4. Gonullu G, Kahraman H, Bedir A, Bektas A, Yucel I. Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis. 2010;25(2):205-12. doi:10.1007/s00384-009-0828-6.
5. Barb D, Pazaitou-Panayiotou K, Mantzoros CS. Adiponectin: a link between obesity and cancer. Expert Opin Investig Drugs. 2006;15(8):917-31. doi:10.1517/13543784.15.8.917.
6. Korner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, et al. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab. 2007;92(3):1041-8. doi:10.1210/jc.2006-1858.
7. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer. 2006;94(9):1221-5. doi: 10.1038/sj.bjc.6603051.
8. Liu L, Zhong R, Wei S, Yin JY, Xiang H, Zou L, et al. Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer. PLoS One. 2011;6(11):e27301. doi:10.1371/journal.pone. 0027301.
9. Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH, et al. Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol. 2010;24(7):1441-52. doi:10.1210/me.2009-0498.
10. Williams CJ, Mitsiades N, Sozopoulos E, Hsi A, Wolk A, Nifli AP, et al. Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr Relat Cancer. 2008;15(1):289-99. doi:10.1677/ERC-07-0197.
11. Dalamaga M, Migdalis I, Fargnoli JL, Papadavid E, Bloom E, Mitsiades N, et al. Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study. Cancer Causes Control. 2009;20(5):625-33. doi:10.1007/s10552-008-9273-z.
12. Ogunwobi OO, Beales IL. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol. 2008;285(1-2):43-50. doi:10.1016/j.mce.2008. 01.023.
13. Mistry T, Digby JE, Chen J, Desai KM, Randeva HS. The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem Biophys Res Commun. 2006;348(3):832-8. doi: 10.1016/j.bbrc.2006.07.139.
14. Otani K, Kitayama J, Kamei T, Soma D, Miyato H, Yamauchi T, et al. Adiponectin receptors are downregulated in human gastric cancer. J Gastroenterol. 2010;45(9):918-27. doi:10.1007/s00535-010-0228-2.
15. Macis D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Magni P, Ruscica M, et al. Prognostic effect of circulating adiponectin in a randomized 2 × 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J Clin Oncol. 2012;30(2):151-7. doi:10.1200/JCO.2011.35.2237.
16. Dal Maso L, Augustin LS, Karalis A, Talamini R, Franceschi S, Trichopoulos D, et al. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab. 2004;89(3):1160-3.
17. Lu JP, Hou ZF, Duivenvoorden WC, Whelan K, Honig A, Pinthus JH. Adiponectin inhibits oxidative stress in human prostate carcinoma cells. Prostate Cancer Prostatic Dis. 2012;15(1):28-35. doi:10.1038/pcan.2011.53.
18. Chen MW, Ye S, Zhao LL, Wang SY, Li YX, Yu CJ, et al. Association of plasma total and high-molecular-weight adiponectin with risk of colorectal cancer: an observational study in Chinese male. Med Oncol. 2012;. doi:10.1007/s12032-012-0280-2.
19. Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res. 2005;11(2 Pt 1):466-72.
20. Ishikawa M, Kitayama J, Yamauchi T, Kadowaki T, Maki T, Miyato H, et al. Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci. 2007;98(7): 1120-7. doi:10.1111/j.1349-7006.2007.00486.x.
21. Kaklamani VG, Sadim M, Hsi A, Offit K, Oddoux C, Ostrer H, et al. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res. 2008;68(9):3178-84. doi:10.1158/0008-5472.CAN-08-0533.
22. Kaklamani V, Yi N, Zhang K, Sadim M, Offit K, Oddoux C, et al. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism. 2011;60(9):1234-43. doi:10.1016/j.metabol. 2011.01.005.
23. Cui E, Deng A, Wang X, Wang B, Mao W, Feng X, et al. The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer. Biochem Cell Biol. 2011;89(3):308-13. doi:10.1139/O11-005.
24. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263-5. doi:10.1093/bioinformatics/bth457.
25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-75. doi:10.1086/519795.
26. Kaklamani VG, Wisinski KB, Sadim M, Gulden C, Do A, Offit K, et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA. 2008;300(13):1523-31. doi:10.1001/jama.300.13. 1523.
27. He B, Pan Y, Zhang Y, Bao Q, Chen L, Nie Z, et al. Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population. BMC Med Genet. 2011;12:94. doi:10.1186/1471-2350-12-94.
28. Carvajal-Carmona LG, Spain S, Kerr D, Houlston R, Cazier JB, Tomlinson I. Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK. Hum Mol Genet. 2009;18(10):1889-92. doi:10.1093/hmg/ ddp109.
29. Gornick MC, Rennert G, Moreno V, Gruber SB. Adiponectin gene and risk of colorectal cancer. Br J Cancer. 2011;105(4): 562-4. doi:10.1038/bjc.2011.259.
30. Shi Y, Hu Z, Wu C, Dai J, Li H, Dong J, et al. A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet. 2011;43(12): 1215-8. doi:10.1038/ng.978.
31. Feneberg A, Malfertheiner P. Epidemic trends of obesity with impact on metabolism and digestive diseases. Dig Dis. 2012;30(2):143-7. doi:10.1159/000336660.
32. Konturek PC, Burnat G, Rau T, Hahn EG, Konturek S. Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig Dis Sci. 2008;53(3):597-605. doi:10.1007/s10620-007-9922-1.
33. Kang JH, Yu BY, Youn DS. Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci. 2007;22(1):117-21.
34. Brakenhielm E, Veitonmaki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA. 2004;101(8): 2476-81.
35. Yamamoto N, Oshima T, Yoshihara K, Sato T, Yamada R, Fujii S, et al. Reduced expression of the AdipoR1 gene is correlated with venous invasion in colorectal cancer. Mol Med Report. 2009;2(4):555-9. doi:10.3892/mmr-00000136.
36. Yamamoto S, Watabe K, Araki H, Kamada Y, Kato M, Kizu T, et al. Protective role of adiponectin against ethanol-induced gastric injury in mice. Am J Physiol Gastrointest Liver Physiol. 2012;302(8):G773-80. doi:10.1152/ajpgi.00324.2011.
37. de Moor CH, Meijer H, Lissenden S. Mechanisms of translational control by the 3′ UTR in development and differentiation. Semin Cell Dev Biol. 2005;16(1):49-58. doi:10.1016/j.semcdb.2004. 11.007.
38. Gui Y, Silha JV, Murphy LJ. Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes Res. 2004;12(9):1481-91. doi:10.1038/oby.2004.185.
39. Sieminska L, Wojciechowska C, Niedziolka D, Marek B, Kos-Kudla B, Kajdaniuk D, et al. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metabolism. 2005;54(12):1610-4. doi:10.1016/j.metabol. 2005. 06.008.
40. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005;280(18):18073-80. doi:10.1074/jbc.M414231200.